axon mcn event - yuen man

14
Perspectives on… A day-in-the-life of Medical Affairs Yuen Man Senior Global Medical Advisor Novo Nordisk 1

Upload: others

Post on 14-May-2022

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: AXON MCN event - Yuen Man

Perspectives on…

A day-in-the-life of Medical Affairs

Yuen Man Senior Global Medical Advisor

Novo Nordisk

1

Page 2: AXON MCN event - Yuen Man

Novo Nordisk at a glance

2

Page 3: AXON MCN event - Yuen Man

Novo Nordisk at a glance

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.

MedCom Event 26 Feb 2016 3 3 Novo Nordisk - Corporate Presentation

PRODUCTS MARKETED IN

180 COUNTRIES

STRATEGIC PRODUCTION SITES

IN BRAZIL, CHINA, DENMARK, FRANCE AND US

SUPPLIER OF MORE THAN

HALF OF THE WORLD’S INSULIN

24,400,000 PEOPLE USE OUR PRODUCTS

AFFILIATES IN COUNTRIES

R&D CENTRES IN CHINA, DENMARK,

INDIA AND US

DKK 88.8 BILLION IN TOTAL REVENUE

200,000 SHAREHOLDERS

75

EMPLOYS APPROXIMATELY

40,000 PEOPLE DIABETES

OBESITY

GROWTH DISORDERS

HAEMOPHILIA

Page 4: AXON MCN event - Yuen Man

Our global presence

MedCom Event 4

REGIONAL HEADQUARTERS 5CHINA, PACIFIC, EUROPE, US AND IO

R&D CENTRES 5 CHINA, DENMARK, INDIA AND US

STRATEGIC PRODUCTION SITES BRAZIL, CHINA, DENMARK, FRANCE, US

5

75 AFFILIATES

NOVO NORDISK MARKETS ITS PRODUCTS IN

COUNTRIES WORLDWIDE 180 DENMARK

GLOBAL HEADQUARTERS

Page 5: AXON MCN event - Yuen Man

•  HQ in Denmark

•  Novo Nordisk Health Care AG – Zurich, Switzerland •  Global Medical Affairs and Marketing Biopharm •  Haemophilia Foundation •  International Operations •  Region Europe

Global presence

5

Page 6: AXON MCN event - Yuen Man

The Triple Bottom Line is how we do business Integrated into the Novo Nordisk Way and our bylaws

6

Page 7: AXON MCN event - Yuen Man

The Novo Nordisk Way •  Our ambition is to strengthen our

leadership in diabetes. •  We aspire to change possibilities in

haemophilia and other serious chronic conditions where we can make a difference.

•  Our key contribution is to discover and develop innovative biological medicines and make them accessible to patients throughout the world.

•  Growing our business and delivering competitive financial results is what allows us to help patients live better lives, offer an attractive return to our shareholders and contribute to our communities.

•  Our business philosophy is one of balancing financial, social and environmental considerations – we call it ‘The Triple Bottom Line’.

•  We are open and honest, ambitious and accountable, and treat everyone with respect.

•  We offer opportunities for our people to realise their potential.

•  We never compromise on quality and business ethics.

7

ZOLA MAKUBALU Local trial South Africa

Page 8: AXON MCN event - Yuen Man

Late stage development:

Controlling progress of late

stage development

projects to ensure competitive data

and label

Medical Affairs involvement throughout milestones

8

Marketed products:

Ensuring data to support LCM activities of marketed

products and fulfilment of

post-approval commitments

Early stage development:

Ensuring optimal programme

design as well as resources for progression of

early stage development

projects

PRE-PROJECT IDEA MANUFACTURING RESEARCH PRE-CLINICAL TESTS

PRODUCT REGISTRATION

CLINICAL TRIALS

REACHING THE MARKET

PREPARING FOR LAUNCH

PHASE 4 TRIALS

Page 9: AXON MCN event - Yuen Man

Global Medical Affairs

Affiliates (local and regional) HCPs

Legal & compliance

Market access &

HEOR

Clinical operations

Medical and

Science Global safety

Stats

Medical writers

R&D

Regulatory

Marketing

Counterparts

9

Page 10: AXON MCN event - Yuen Man

Air traffic control

10

Page 11: AXON MCN event - Yuen Man

Global Medical Affairs

Affiliates (local and regional) HCPs

Legal & compliance

Market access &

HEOR

Clinical operations

Medical and

Science Global safety

Stats

Medical writers

R&D

Regulatory

Marketing

Counterparts

11

Marketing Agency

Market Research Agency

HEOR Agency

Medical Agency 1

Medical Agency 2

Medical Agency 3

Page 12: AXON MCN event - Yuen Man

•  Understand scientific content •  Reflect on content •  Effective communication •  Continuity of developed materials

•  Efficient / fast •  Creative •  Engaged

•  Up to date on compliance, business ethics •  Good KOL management •  Excellent project management

Medical agency support – what are we looking for?

12

Page 13: AXON MCN event - Yuen Man

•  Is a 3rd arm to Medical Affairs

•  Understands the strategy •  Is up-to-date on the therapy area and changing competitor landscape

•  Strategic input and guidance •  Facilitation of meetings/workshops /slide reviews (internal and external)

•  Common sense •  Partner to trust

A really good medical agency…

13

Page 14: AXON MCN event - Yuen Man

Thank you for your attention

14